Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past 24 hours
Any time
Past hour
Past 7 days
Past 30 days
Most recent
Best match
14h
Kisqali wins FDA nod for breast cancer treatment: Dosage, effectiveness and side effects of the breakthrough drug
The US FDA has approved Kisqali (ribociclib) for treating early-stage breast cancer in combination with hormone therapy. It ...
Medscape
21h
FDA OKs Adjuvant Ribociclib in Earlier Stage Breast Cancer
Unlike rival CDK 4/6 inhibitor abemaciclib, patients don't need to be lymph-node positive to receive ribociclib after surgery ...
biopharma-reporter
22h
Novartis’ Kisqali receives FDA approval to reduce the risk of breast cancer recurrence
Novartis announced this week that the FDA has approved ribociclib (marketed as Kisqali) for the treatment of people with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Kentucky judge fatally shot
Cancels appearance w/ Duda
Hold campaign event in MI
Boy kills bear, saves father
Israel strikes Hezbollah
To receive Holbrooke award
PGA welcomes LIV players
Families lose appeal
To get a second moon
Joins Motion Picture Assn.
Ban called for in TX schools
Existing home sales drop
Vows to remain in race
Overdose deaths drop in US
Collapse hazard recall
Man charged for threats
Brazil threatens daily fines
COVID, Wuhan market link
EU warns Apple
Rally attendees injured
FTC on privacy controls
160M euros to Ukraine
Dow, S&P hit record highs
NYC subway joyride arrest
Gun case sentencing delay
Deal to build new arena
Retires after 17 seasons
US healthcare system falls
Hails economic progress
UN backs Palestine
US jobless claims fall
Makes MLB history
Feedback